指标,分层,N,治疗组变化,对照组变化,差异,P值,显著
ALT,全人群,171,-0.989247311827957,0.41025641025641024,-1.3995037220843671,0.5346164415338901,否
ALT,基线异常,22,-7.0,-3.8,-3.2,0.5520983603168993,否
ALT,基线正常,149,-0.09876543209876543,1.0294117647058822,-1.1281771968046477,0.5984108699363668,否
AST,全人群,171,0.946236559139785,0.5769230769230769,0.3693134822167081,0.4381171631372943,否
AST,基线异常,17,-7.777777777777778,6.875,-14.652777777777779,0.21068182941043767,否
AST,基线正常,154,1.880952380952381,-0.14285714285714285,2.0238095238095237,0.15444277835856177,否
肝硬度值,全人群,126,-3.983116883116883,-2.7795918367346935,-1.2035250463821896,0.02874198576531716,是
肝硬度值,基线异常,124,-4.026315789473684,-2.835416666666667,-1.190899122807017,0.030589785720981606,是
